Elevated levels of protein phosphatase 1 and phosphatase 2A may contribute to cardiac dysfunction in diabetes

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1638, Issue 3, 2003, Pages 273-277

  Rastogi, Sharad ^b   Sentex, Emmanuelle ^b   Elimban, Vijayan ^b   Dhalla, Naranjan S ^b   Netticadan, Thomas ^a  

^a ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

^b NONE

Author keywords

Cardiac dysfunction; Diabetes; Diabetic heart; Protein dephosphorylation; Protein phosphatase

Indexed keywords

INSULIN; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; STREPTOZOCIN; PROTEIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; HEART DISEASE; INSULIN TREATMENT; MALE; NONHUMAN; OBSERVATION; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DEPHOSPHORYLATION; PROTEIN FUNCTION; RAT; RAT STRAIN; ANIMAL; DRUG EFFECT; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; HEART; HEART CONTRACTION; HEART MUSCLE; METABOLISM; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALIA;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; HEART; INSULIN; MALE; MYOCARDIAL CONTRACTION; MYOCARDIUM; PHOSPHOPROTEIN PHOSPHATASE; PROTEINS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0142075748     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4439(03)00092-9     Document Type: Article

References (26)

1. Ganguly P.K., Pierce G.N., Dhalla K.S., Dhalla N.S. Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy. Am. J. Physiol. 244:1983;E528-E535.
2. 2+-cycling proteins may underlie sarcoplasmic reticulum dysfunction in the diabetic heart. Diabetes. 50:2001;2133-2138.
3. 2+-overload. J. Physiol. 527:2000;85-94.
4. Zhong Y., Ahmed S., Grupp I.L., Matlib M.A. Altered SR protein expression associated with contractile dysfunction in diabetic rat hearts. Am. J. Physiol. 281:2001;H1137-H1147.
5. 2+-channels during the development of diabetic cardiomyopathy. Mol. Cell. Biochem. 109:1992;173-179.
6. 2+ transport in streptozotocin-induced diabetic cardiomyopathy in rats. Am. J. Physiol. 253:1987;E202-E207.
7. Lopaschuk G.D., Tahiliani A.G., Vadlamudi R.V., Katz S., McNeill J.H. Cardiac sarcoplasmic reticulum function in insulin- or carnitine-treated diabetic rats. Am. J. Physiol. 245:1983;H969-H976.
8. Pierce G.N., Dhalla N.S. Mechanisms of the defect in cardiac myofibrillar function during diabetes. Am. J. Physiol. 248:1985;E170-E175.
9. Liu X., Takeda N., Dhalla N.S. Troponin I phosphorylation in heart homogenate from diabetic rat. Biochim. Biophys. Acta. 1316:1996;78-84.
10. Liu X., Takeda N., Dhalla N.S. Myosin light-chain phosphorylation in diabetic cardiomyopathy in rats. Metabolism. 46:1997;71-75.
11. Rapundalo S.T. Cardiac protein phosphorylation: functional and pathophysiological correlates. Cardiovasc. Res. 38:1998;559-588.
12. Xiang H., McNeill J.H. Protein kinase C activity is altered in diabetic rat hearts. Biochem. Biophys. Res. Commun. 187:1992;703-710.
13. Liu X., Wang J., Takeda N., Binaglia L., Panagia V., Dhalla N.S. Changes in cardiac protein kinase C activities and isozymes in streptozotocin-induced diabetes. Am. J. Physiol. 277:1999;E798-E804.
14. Cohen P. The structure and regulation of protein phosphatases. Ann. Rev. Biochem. 58:1989;453-508.
15. MacDougall L.K., Jones L.R., Cohen P. Identification of the major protein phosphatases in mammalian cardiac muscle which dephosphorylate phospholamban. Eur. J. Biochem. 196:1991;725-734.
16. Foulkes J.G., Jefferson L.S. Protein phosphatase-1 and -2A activities in heart, liver, and skeletal muscle extracts from control and diabetic rats. Diabetes. 33:1984;576-579.
17. Ingebritsen T.S., Stewart A.A., Cohen P. The protein phosphatases involved in type-1 and type-2 protein phosphatases in extracts of mammalian tissues; an assessment of their physiological roles. Eur. J. Biochem. 132:1983;297-307.
18. Neumann J., Boknik P., Herzig S., Schmitz W., Scholz H., Gupta R.C., Watanabe A.M. Evidence for physiological functions of protein phosphatases in the heart: evaluation with okadaic acid. Am. J. Physiol. 265:1993;H257-H266.
19. Jaspers S.R., Miller T.B. Jr. Purification and the immunological characterization of rat protein phosphatase 2A: enzyme levels in diabetic liver and heart. Mol. Cell. Biochem. 101:1991;167-174.
20. Tahiliani A.G., Vadlamudi R.V., McNeill J.H. Prevention and reversal of altered myocardial function in diabetic rats by insulin treatment. Can. J. Physiol. Pharm. 61:1983;516-523.
21. Mihm M.J., Seifert J.L., Coyle C.M., Bauer J.A. Diabetes related cardiomyopathy time dependent echocardiographic evaluation in an experimental rat model. Life Sci. 69:2001;527-542.
22. Takeda N., Dixon I.M., Hata T., Elimban V., Shah K.R., Dhalla N.S. Sequence of alterations in subcellular organelles during the development of heart dysfunction in diabetes. Diabetes Res. Clin. Pract. 30:1996;113-122.
23. Davare M.A., Horne M.C., Hell J.W. Protein phosphatase 2A is associated with class C L-type calcium channels (Cav1.2) and antagonizes channel phosphorylation by cAMP-dependent protein kinase. J. Biol. Chem. 275:2000;39710-39717.
24. Zhao S., Brandt N.R., Caswell A.H., Lee E.Y. Binding of the catalytic subunit of protein phosphatase-1 to the ryanodine-sensitive calcium release channel protein. Biochemistry. 37:1998;18102-18109.
25. Steenaart N.A., Ganim J.R., Di Salvo J., Kranias E.G. The phospholamban phosphatase associated with cardiac sarcoplasmic reticulum is a type 1 enzyme. Arch. Biochem. Biophys. 293:1992;17-24.
26. Davis B.A., Edes I., Gupta R.C., Young E.F., Kim H.W., Steenaart N.A., Szymanska G., Kranias E.G. The role of phospholamban in the regulation of calcium transport by cardiac sarcoplasmic reticulum. Mol. Cell. Biochem. 99:1990;83-88.